The estimated Net Worth of Jean Marc Huet is at least $1.21 Milion dollars as of 30 April 2009. Jean Huet owns over 25,000 units of Bristol-Myers Squibb Co stock worth over $1,214,750 and over the last 16 years Jean sold BMY stock worth over $0.
Sign up
Jean Huet BMY stock SEC Form 4 insiders trading
Jean has made over 1 trades of the Bristol-Myers Squibb Co stock since 2009, according to the Form 4 filled with the SEC. Most recently Jean bought 25,000 units of BMY stock worth $481,250 on 30 April 2009.
The largest trade Jean's ever made was buying 25,000 units of Bristol-Myers Squibb Co stock on 30 April 2009 worth over $481,250. On average, Jean trades about 8,333 units every 0 days since 2009. As of 30 April 2009 Jean still owns at least 25,000 units of Bristol-Myers Squibb Co stock.
You can see the complete history of Jean Huet stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Jean Huet's mailing address?
Jean's mailing address filed with the SEC is BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, PRINCETON, NJ, 08543.
Insiders trading at Bristol-Myers Squibb Co
Over the last 17 years, insiders at Bristol-Myers Squibb Co have traded over $318,151,721 worth of Bristol-Myers Squibb Co stock and bought 211,503 units worth $6,601,565 . The most active insiders traders include Lamberto Andreotti, James M Cornelius a Giovanni Caforio. On average, Bristol-Myers Squibb Co executives and independent directors trade stock every 8 days with the average trade being worth of $1,682,720. The most recent stock trade was executed by Cari Gallman on 1 August 2024, trading 1,061 units of BMY stock currently worth $51,554.
What does Bristol-Myers Squibb Co do?
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
What does Bristol-Myers Squibb Co's logo look like?
Complete history of Jean Huet stock trades at Bristol-Myers Squibb Co
Bristol-Myers Squibb Co executives and stock owners
Bristol-Myers Squibb Co executives and other stock owners filed with the SEC include:
-
Giovanni Caforio,
Chairman of the Board, Chief Executive Officer -
Sandra Leung,
Executive Vice President, General Counsel -
Dr. Giovanni Caforio M.D.,
Chairman & CEO -
Christopher Boerner,
Executive Vice President and Chief Commercial Officer -
David Elkins,
Executive Vice President and Chief Financial Officer Member of the Leadership Team -
Rupert Vessey,
Executive Vice President, Research and Early Development Member of the Leadership Team -
Louis Schmukler,
Executive Vice President, President - Global Product Development and Supply -
David V. Elkins,
Exec. VP & CFO -
Rupert Vessey BCH, BM, DPHIL, M.A.,
Exec. VP and Pres of Research & Early Devel. -
Sandra Leung Esq.,
Exec. VP & Gen. Counsel -
Dr. Christopher S. Boerner,
Exec. VP & Chief Commercialization Officer -
Vicki Sato,
Lead Independent Director -
Matthew Emmens,
Independent Director -
Peter Arduini,
Independent Director -
Dinesh Paliwal,
Independent Director -
Theodore Samuels,
Independent Director -
Karen Vousden,
Independent Director -
Robert Bertolini,
Independent Director -
Gerald Storch,
Independent Director -
Phyllis Yale,
Independent Director -
Julia Haller,
Independent Director -
Michael Bonney,
Independent Director -
Derica Rice,
Independent Director -
Paula Price,
Independent Director -
Tim Power,
Vice President of Investor Relations -
Joseph Eid,
Senior Vice President and Head of Global Medical Affairs Member of the Leadership Team -
Karen Santiago,
Senior Vice President, Corporate Controller -
Adam Dubow,
Senior Vice President, Chief Compliance Officer and Ethics Officer -
Paul von Autenried,
Chief Information Officer, Senior Vice President -
Elizabeth Mily,
Executive Vice President - Strategy & Business Development -
Kathryn Metcalfe,
Executive Vice President - Corporate Affairs Member of the Leadership Team -
Samit Hirawat,
Executive Vice President, Chief Medical Officer, Global Drug Development Member of the Leadership Team -
Nadim Ahmed,
Executive Vice President and President - Hematology -
John Elicker,
Executive Vice President of Investor Relations -
Ann Judge,
Chief Human Resource Officer, Senior Vice President Member of the Leadership Team -
Ann M. Powell Judge,
Exec. VP & Chief HR Officer -
Adam Dubow,
Sr. VP, Chief Compliance & Ethics Officer -
Timothy Power,
VP & Head of Investor Relations -
Paul von Autenried,
Exec. VP & Chief Information Officer -
Greg Meyers,
Exec. VP and Chief Digital & Technology Officer -
Jose Baselga,
Director -
Alan J Lacy,
Director -
Joseph C Caldarella,
VP & Financial Controller -
Anne Nielsen,
Chief Compliance & Ethics Off -
Laurie H M.D. Glimcher,
Director -
Michael Grobstein,
Director -
Togo D Jr West,
Director -
Emmanuel Blin,
SVP, Head of Commercialization -
Francis M Cuss,
SVP Dscvry & Exp Clinl Resrch -
Murdo Gordon,
SVP, Head of Worldwide Markets -
Thomas J. Jr. Lynch,
Director -
Karin Shanahan,
EVP, Glob. Prod. Dev. & Supply -
Lynelle Hoch,
President, Cell Therapy Org. -
Phil M Holzer,
SVP and Controller -
Ahn Amanda Poole,
EVP, Chief Human Resources -
Samuel J Moed,
SVP, Strat Plan & Analysis -
Michelle Weese,
EVP, Corporate Affairs -
Paul Biondi,
SVP, Head of Strategy & BD -
Charles A Bancroft,
EVP, Head of Integration -
Ann Powell,
EVP, Chief Human Resources -
Frances K Heller,
SVP, Business Development -
Brian Daniels,
SVP Global Development -
Elliot Sigal,
EVP, CSO & President R&D -
Beatrice J Cazala,
SVP Comm Ops & Pres GC Euro EM -
Robert T Zito,
SVP & Chief Comm Officer -
Jeremy M Levin,
SVP Strat Transactions -
R Sanders Williams,
Director -
Anthony C Hooper,
President US Pharmaceuticals -
Louis J Freeh,
Director -
Anthony A Mcbride,
SVP Human Resources -
De Notaristefani Carlo,
President, Tech Ops -
Leif Johansson,
Director -
John E Celentano,
SVP Strat & Productivity Trans -
Jean Marc Huet,
SVP & CFO -
James M Cornelius,
Chairman & CEO -
Lewis B Campbell,
Director -
Medina Manuel Hidalgo,
Director -
Benjamin Hickey,
President, RayzeBio Org. -
Gregory Scott Meyers,
EVP, Chief Digital & Tech Off. -
Sharon Greenlees,
SVP & Controller -
Deepak Bhatt,
Director -
Michael R. Mc Mullen,
Director -
Adam Lenkowsky,
EVP, Chief Commercial Officer -
Robert M Plenge,
EVP, Chief Research Officer -
Cari Gallman,
EVP, Corporate Affairs